ArticlePublisher preview available

Strategies for Developing Clinical Services—Advanced Practice Programs

Authors:
To read the full-text of this research, you can request a copy directly from the author.

Abstract and Figures

The Director's Forum series of articles switches its focus from the core competencies of hospital pharmacy practice to programs that enhance the ability of the pharmacy to provide patient-centered services. In the September 2006 issue, decentralized pharmacy services were reviewed and recommended as an effective patient-centered strategy for a hospital pharmacy. This issue addresses developing advanced practice programs in critical care.
This content is subject to copyright.
Hospital
Pbarmacy
Volume 41, Number 10, pp 986-992
2006 Wolters Kluwer Health, Inc.
Director's
Forum
Strategies
for
Developing
Clinical
Services-
Advanced
Practice
Programs
Robert j. Weber, MS, FASHP *
..Associate Professor and Chair, University of Pittsburgh School of Pharmacy, Execu-
tive Director of Pharmacy, University of Pittsburgh Medical Center
The Director's Forum series of articles switches its focus from the core
competencies of hospital pharmacy practice to programs that enhance the
ability of the pharmacy to provide patient-centered
services.
In the
Sep-
tember 2006
issue,
decentralized pharmacy services were reviewed and
recommended as an effective patient-centered strategy for a hospital
pharmacy.This issueaddresses developing advanced practiceprograms in
critical care.
Decentralized pharmacy ser-
vices places pharmacists
closer to patients, enhanc-
ing their ability to be involved
directly in medication
order
review, drug dispensing, medica-
tion therapy management,
and
patient education. A recent review
of
the role of pharmacists in
patient care describes a growing
body of literature documenting
pharmacists' activities in improv-
ing the quality of care. 1The decen-
tralized services previously
described highlight order review
and processing, formulary man-
agement,
and
therapeutic drug
monitoring. In addition, the article
stressed
that
satellite pharmacy
services
are
not
necessarily a
requirement for providing decen-
tralized services. In fact, a pilot
experience at the University of
Pittsburgh Medical Center demon-
strated the success of decentraliz-
ing pharmacists and technicians
while maintaining pharmacy cen-
tralized operations and batch med-
ication fill processes.'
While basic decentralized ser-
vices positively impact patient
care, there is tremendous value in
providing advanced practice phar-
macy services.
The
American
Society of Health-System Pharma-
cists (ASHP) published adraft
report on its vision for the phar-
macy workforce in hospitals and
health systems, stating that assur-
ing the safe and effective use of
medication in health systems is
dependent on a diverse workforce
of leaders, general practitioners,
and specialized pharmacists.' The
ASHP position paper also states
that
pharmacists working in spe-
cialized areas will have completed
the
appropriate
post-graduate
training and obtained proper cer-
tification and credentials, distin-
guishing them from generalist
pharmacy practitioners.
Pharmacists engaged in
advanced practice may impact the
care of patients in a more direct
way. As an example, pharmacists
with training in critical care, or
oncology may be more effective in
preventing medication errors in
the intensive care unit (ICU) or in
an oncology clinic, compared
with pharmacists with generalist
training and education. This is
primarily because of these special-
ist pharmacists' ability to effec-
tively apply evidence-based crite-
ria for medication use to clinical
scenarios with ICU or oncology
patients.
The
previously referenced
meta-analysis by Kaboli and col-
leagues
that
describes the impact
of clinical pharmacists in hospital-
ized patients showed that services
provided by these pharmacists
resulted in improved care and
improved outcomes. Further
analysis of pharmacists' activities
in specialty areas (eg, psychiatry,
geriatrics, critical care) showed
positive clinical outcomes in
reduced medication errors,
reduced adverse drug events, and
reduced numbers of medications
prescribed for those special
patient populations.
Every hospital pharmacy
director should consider establish-
ing advanced practice pharmacy
services in order to provide for the
highest quality patient-centered
care. To accomplish this, the phar-
macy director is often faced with
the following leadership chal-
lenges: (1) How do you determine
the specialty area to establish an
advanced practice site? (2) What
steps are necessary to justify an
advanced practice pharmacy pro-
gram?
986
Volume
41, October 2006
Article
Full-text available
The Director's Forum series is written and edited by Michael Sanborn and Robert Weber and is designed to guide pharmacy leaders in establishing patient-centered services in hospitals and health systems. Another specific goal of this column is to address many of the key challenges that pharmacy directors face today, while providing information to foster growth in pharmacy leadership and patient safety. This month's Forum focuses on specific ways to improve the medication-use evaluation process.
Article
Full-text available
The initial installments of the Director's Forum reviewed key core competencies necessary for a pharmacy department to define their value in patient care. Core competencies include medication order review, medication order dispensing, and preparing intravenous (IV) admixtures. The next article will review the final core competency: compliance with regulatory standards. Additional pharmacy department programs such as medication therapy management and patient safety are also critical in establishing a patient-centered focus, and will be discussed in future articles.
Article
Full-text available
A drug-use and disease-state management (DUDSM) program was instituted in 1996 at a teaching hospital associated with a large nonprofit health care system. The program's goals are to optimize pharmacotherapeutic regimens, evaluate health outcomes of identified disease states, and evaluate the economic impact of pharmacotherapeutic options for given disease states by developing practice guidelines. Through a re-engineering process, resources within the pharmacy department were identified that could be devoted to the DUDSM program, including the use of clinical pharmacy specialists, promotion of staff pharmacists into the DUDSM program, a pharmacy technician, and information systems support. A strength of the program is its systematic approach for developing and implementing new initiatives, as well as monitoring compliance with all initiatives on an ongoing basis. The initiative-design process incorporates continuous quality improvement principles, outcome design and evaluation, competency assessment for all pharmacists, multidisciplinary collaboration, and sophisticated information systems. Seventy-five initiatives have been implemented, ranging from simple dose-optimization strategies for specific drugs to complicated practice guidelines for managing specific disease states. Improved patient outcomes have been documented, including reduced length of stay, postsurgical wound infection, adverse drug reactions, and medication errors. Documented cost savings exceeded $4 million annually for fiscal years 1996-97 through 1999-2000. Overall compliance with DUDSM initiatives exceeds 80%, and physician service profiling has been initiated to monitor variant prescribing. The DUDSM program has successfully integrated practice guidelines into therapeutic decision-making, resulting in improved patient-care outcomes and cost savings.
Article
Purpose This project deployed pharmacist and technician teams on patient care units to improve (1) the quality of the medication process and (2) nurse satisfaction with pharmacy services. Methods An interdisciplinary team developed a decentralized pharmacy model, establishing complimentary roles for pharmacists and technicians based on their current roles, expected roles, and published evidence. A trained nurse or pharmacist observed the medication process before and after implementing the service model; nurses were surveyed for satisfaction with pharmacy services. Statistical analysis of changes in order-processing times and nurse satisfaction were determined using an independent samples t-test (CI = 0.95, P < 0.05). Results Two processes were significantly improved before after implementing the decentralized model (PRE vs POST): (1) order entry time, PRE 24.4 ± 18.1 min (Mean ± SD) vs POST 12.1 ± 10.5 min, P = 0.001; (2) order delivery time, PRE 50.5 ± 18.9 min vs POST 27.5 ± 15.2 min, P = 0.048. Nursing satisfaction significantly improved after implementation of the decentralized model, specifically in perception of quality, PRE (Median score = 3) vs POST (Median score = 4), P = 0.04, timely delivery of STAT and routine medications PRE (Median score = 2) vs POST (Median Score = 4, P = 0.00, pharmacy as an asset to patient care PRE (Median score = 3) vs POST (Median Score = 5), P = 0.04, and effective pharmacy and nursing communication PRE (Median score = 2) vs POST (Median Score = 4), P = 0.04. Pharmacists increased their medication safety interventions and documentation almost five-fold. Conclusions Pharmacist-technician teams on the patient care units improved service and nurse satisfaction and may be a useful method for decentralizing pharmacy services in hospitals that do not have satellites.
Article
The role of clinical pharmacists in the care of hospitalized patients has evolved over time, with increased emphasis on collaborative care and patient interaction. The purpose of this review was to evaluate the published literature on the effects of interventions by clinical pharmacists on processes and outcomes of care in hospitalized adults. Peer-reviewed, English-language articles were identified from January 1, 1985, through April 30, 2005. Three independent assessors evaluated 343 citations. Inpatient pharmacist interventions were selected if they included a control group and objective patient-specific health outcomes; type of intervention, study design, and outcomes such as adverse drug events, medication appropriateness, and resource use were abstracted. Thirty-six studies met inclusion criteria, including 10 evaluating pharmacists' participation on rounds, 11 medication reconciliation studies, and 15 on drug-specific pharmacist services. Adverse drug events, adverse drug reactions, or medication errors were reduced in 7 of 12 trials that included these outcomes. Medication adherence, knowledge, and appropriateness improved in 7 of 11 studies, while there was shortened hospital length of stay in 9 of 17 trials. No intervention led to worse clinical outcomes and only 1 reported higher health care use. Improvements in both inpatient and outpatient outcome measurements were observed. The addition of clinical pharmacist services in the care of inpatients generally resulted in improved care, with no evidence of harm. Interacting with the health care team on patient rounds, interviewing patients, reconciling medications, and providing patient discharge counseling and follow-up all resulted in improved outcomes. Future studies should include multiple sites, larger sample sizes, reproducible interventions, and identification of patient-specific factors that lead to improved outcomes.
Draft: Long range vision for the pharmacy work force in hospitals and health systems Am
  • Anon
Anon. Draft: Long range vision for the pharmacy work force in hospitals and health systems Am ] Health Syst Pharm. 2006;63:661-665.